CVE-2022-29071 Explained : Impact and Mitigation

A detailed overview of CVE-2022-29071, a vulnerability found in the on-premises deployment model of Arista CloudVision Portal (CVP) affecting various versions.

Understanding CVE-2022-29071

This vulnerability exposes a flaw in the CloudVision Portal (CVP) deployment where user passwords can be leaked under specific conditions, potentially leading to unauthorized access.

What is CVE-2022-29071?

CVE-2022-29071 is an internally found vulnerability in Arista CloudVision Portal (CVP) that can result in user login passwords being leaked to other authenticated users, posing a security risk.

The Impact of CVE-2022-29071

The impact of this vulnerability is significant as it could allow unauthorized users to access sensitive information, compromising system security and user data.

Technical Details of CVE-2022-29071

Here are the technical aspects associated with CVE-2022-29071:

Vulnerability Description

The vulnerability allows user passwords to be leaked in the Audit and System logs within the on-premises deployment model of Arista CloudVision Portal (CVP).

Affected Systems and Versions

The vulnerability affects multiple versions of CloudVision Portal, including 2020.2, 2020.3, 2021.1, 2021.2, and 2021.3, prior to remediation.

Exploitation Mechanism

Under specific conditions, user passwords can be exposed in the logs, potentially leading to password leaks among authenticated users.

Mitigation and Prevention

To address CVE-2022-29071 and enhance security measures, follow these recommendations:

Immediate Steps to Take

Upgrade to the remediated software versions, such as CVP 2022.1.1 and CVP 2022.2.0 once released.

Long-Term Security Practices

Change passwords regularly and ensure strong, unique passwords for user accounts.
Restrict access to the CVP application and host operating system to trusted users or groups.

Patching and Updates

Stay informed about security patches and updates from Arista Networks to protect your system from potential vulnerabilities.